{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T07:15:12Z","timestamp":1784099712778,"version":"3.55.0"},"reference-count":74,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,1,22]],"date-time":"2009-01-22T00:00:00Z","timestamp":1232582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[2009,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Siglecs (sialic acid\u2010binding, Ig\u2010like lectins) are a family of single\u2010pass transmembrane cell surface proteins found predominantly on leucocytes. Their unique structural characteristics include an N\u2010terminal carbohydrate\u2010binding (\u2018lectin\u2019) domain that binds sialic acid, followed by a variable number of Ig\u2010like domains, hence these structures are a subset of the Ig gene superfamily. Another unique feature of Siglecs is that most, but not all, possess so\u2010called immunoreceptor tyrosine\u2010based inhibitory motifs in their cytoplasmic domains, suggesting that these molecules function in an inhibitory capacity. Siglec\u20108, the eighth member identified at the time, was discovered as part of an effort initiated almost a decade ago to identify novel human eosinophil and mast cell proteins. Since that time, its selective expression on human eosinophils and mast cells has been confirmed. On eosinophils, Siglec\u20108 engagement results in apoptosis, whereas on mast cells, inhibition of Fc\u025bRI\u2010dependent mediator release, without apoptosis, is seen. It has subsequently been determined that the closest functional paralog in the mouse is Siglec\u2010F, selectively expressed by eosinophils but not expressed on mast cells. Despite only modest homology, both Siglec\u20108 and Siglec\u2010F preferentially recognize a sulphated glycan ligand closely related to sialyl Lewis X, a common ligand for the selectin family of adhesion molecules. Murine experiments in normal, Siglec\u2010F\u2010deficient mice and hypereosinophilic mice have resulted in similar conclusions that Siglec\u2010F, like Siglec\u20108, plays a distinctive and important role in regulating eosinophil accumulation and survival <jats:italic>in vivo<\/jats:italic>. Given the resurgent interest in eosinophil\u2010directed therapies for a variety of disorders, plus its unique additional ability to also target the mast cell, therapies focusing on Siglec\u20108 could some day prove to be a useful adjunct to our current armamentarium for the treatment of asthma, allergies and related disorders where overproduction and overactivity of eosinophils and mast cells is occurring.<\/jats:p>","DOI":"10.1111\/j.1365-2222.2008.03173.x","type":"journal-article","created":{"date-parts":[[2009,1,23]],"date-time":"2009-01-23T04:16:24Z","timestamp":1232684184000},"page":"317-324","source":"Crossref","is-referenced-by-count":153,"title":["Siglec\u20108 on human eosinophils and mast cells, and Siglec\u2010F on murine eosinophils, are functionally related inhibitory receptors"],"prefix":"10.1111","volume":"39","author":[{"given":"B. S.","family":"Bochner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,1,28]]},"reference":[{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(05)88004-6"},{"key":"e_1_2_10_3_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-065X.2001.790118.x"},{"key":"e_1_2_10_4_2","first-page":"5","article-title":"Mast cells, basophils, and eosinophils","volume":"179","author":"Bochner BS","year":"2001","journal-title":"distinct but overlapping pathways for recruitment"},{"key":"e_1_2_10_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2007.07.004"},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61449-X"},{"key":"e_1_2_10_7_2","first-page":"3","article-title":"Verdict in the case of therapies versus eosinophils","volume":"113","author":"Bochner BS.","year":"2004","journal-title":"the jury is still out"},{"key":"e_1_2_10_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003559.pub3"},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2008.01723.x"},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(08)00403-3"},{"key":"e_1_2_10_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070812"},{"key":"e_1_2_10_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.05.031"},{"key":"e_1_2_10_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.12.191"},{"key":"e_1_2_10_14_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.6.3850"},{"key":"e_1_2_10_15_2","first-page":"320","article-title":"\u201cAccentuate the negative, eliminate the positive\u201d","volume":"121","author":"Saxon A","year":"2008","journal-title":"engineering allergy therapeutics to block allergic reactivity through negative signaling"},{"key":"e_1_2_10_16_2","first-page":"v","article-title":"Siglecs","volume":"8","author":"Crocker PR","year":"1998","journal-title":"a family of sialic-acid binding lectins"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwj008"},{"key":"e_1_2_10_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature05816"},{"key":"e_1_2_10_19_2","first-page":"609","article-title":"Siglecs","volume":"12","author":"Crocker PR.","year":"2002","journal-title":"sialic-acid-binding immunoglobulin-like lectins in cell\u2013cell interactions and signalling"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2005.03.003"},{"key":"e_1_2_10_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri2056"},{"key":"e_1_2_10_22_2","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1443.011"},{"key":"e_1_2_10_23_2","volume-title":"Allergy frontiers: from epigenetics to future perspectives","author":"Von Gunten S","year":"2009"},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V62.1.124.124"},{"key":"e_1_2_10_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(84)90001-8"},{"key":"e_1_2_10_26_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2000.107127"},{"key":"e_1_2_10_27_2","first-page":"861","article-title":"Siglec\u20108","volume":"275","author":"Floyd H","year":"2000","journal-title":"a novel eosinophil-specific member of the immunoglobulin superfamily"},{"key":"e_1_2_10_28_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2000.3866"},{"key":"e_1_2_10_29_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2002.120550"},{"key":"e_1_2_10_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.04.040"},{"key":"e_1_2_10_31_2","first-page":"130","volume-title":"Allergy frontiers and futures, Proceedings of the 24th Symposium of the Collegium Internationale Allergologicum","author":"Nutku E","year":"2004"},{"key":"e_1_2_10_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1119(02)00432-8"},{"key":"e_1_2_10_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.12.047"},{"key":"e_1_2_10_34_2","first-page":"5014","article-title":"Ligation of Siglec\u20108","volume":"101","author":"Nutku E","year":"2003","journal-title":"a selective mechanism for induction of human eosinophil apoptosis"},{"key":"e_1_2_10_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-9725.2004.00037.x"},{"key":"e_1_2_10_36_2","first-page":"918","article-title":"Mechanism of Siglec\u20108\u2010induced human eosinophil apoptosis","volume":"336","author":"Nutku E","year":"2005","journal-title":"role of caspases and mitochondrial injury"},{"key":"e_1_2_10_37_2","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2007-0154OC"},{"key":"e_1_2_10_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2006.01133.x"},{"key":"e_1_2_10_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.10.004"},{"key":"e_1_2_10_40_2","first-page":"23","article-title":"Surface expression, inhibitory function and candidate ligand for Siglec\u20108 on human mast cells","author":"Yokoi H","year":"2007","journal-title":"Cellular and Molecular Targets in Allergy and Clinical Immunology"},{"key":"e_1_2_10_41_2","first-page":"11","article-title":"Immunoreceptor tyrosine\u2010based inhibition motifs","volume":"224","author":"Daeron M","year":"2008","journal-title":"a quest in the past and future"},{"key":"e_1_2_10_42_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.11.6841"},{"key":"e_1_2_10_43_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M403538200"},{"key":"e_1_2_10_44_2","doi-asserted-by":"publisher","DOI":"10.1159\/000057747"},{"key":"e_1_2_10_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2006.01171.x"},{"key":"e_1_2_10_46_2","doi-asserted-by":"publisher","DOI":"10.1385\/1-59259-967-2:077"},{"key":"e_1_2_10_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.01.023"},{"key":"e_1_2_10_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3038.2007.00516.x"},{"key":"e_1_2_10_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3038.2007.00657.x"},{"key":"e_1_2_10_50_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02033.x"},{"key":"e_1_2_10_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)61714-0"},{"key":"e_1_2_10_52_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0407902101"},{"key":"e_1_2_10_53_2","doi-asserted-by":"publisher","DOI":"10.1134\/S0006297906050051"},{"key":"e_1_2_10_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2006.03.223"},{"key":"e_1_2_10_55_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M412378200"},{"key":"e_1_2_10_56_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-149641"},{"key":"e_1_2_10_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.12.1042"},{"key":"e_1_2_10_58_2","first-page":"521","article-title":"Molecular analysis of human Siglec\u20108 orthologs relevant to mouse eosinophils","volume":"82","author":"Aizawa H","year":"2003","journal-title":"identification of mouse orthologs of Siglec-5 (mSiglec-F) and Siglec-10 (mSiglec-G)"},{"key":"e_1_2_10_59_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni1480"},{"key":"e_1_2_10_60_2","first-page":"45128","article-title":"Cloning and characterization of a novel mouse Siglec, mSiglec\u2010F","volume":"276","author":"Angata T","year":"2001","journal-title":"differential evolution of the mouse and human (CD33) Siglec-3-related gene clusters"},{"key":"e_1_2_10_61_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200324723"},{"key":"e_1_2_10_62_2","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwi097"},{"key":"e_1_2_10_63_2","first-page":"54","article-title":"Siglec\u20108 and Siglec\u2010F","volume":"19","author":"Guo JP","year":"2007","journal-title":"inhibitory receptors on eosinophils, basophils and mast cells"},{"key":"e_1_2_10_64_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-08-039255"},{"key":"e_1_2_10_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2007.07.011"},{"key":"e_1_2_10_66_2","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1106686"},{"key":"e_1_2_10_67_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.7.4766"},{"key":"e_1_2_10_68_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200737553"},{"key":"e_1_2_10_69_2","first-page":"1693","article-title":"Eosinophils from lineage\u2010ablated delta dblGATA bone marrow progenitors","volume":"179","author":"Dyer KD","year":"2007","journal-title":"the dblGATA enhancer in the promoter of GATA-1 is not essential for differentiation ex vivo"},{"key":"e_1_2_10_70_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.6.4004"},{"key":"e_1_2_10_71_2","first-page":"A690","article-title":"Anti\u2010Siglec\u2010F antibody treatment during allergen\u2010induced airway inflammation reduces eosinophil numbers but has no effect on airway hyperreactivity in vivo","volume":"175","author":"Kearley J","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_2_10_72_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2008.01709.x"},{"key":"e_1_2_10_73_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00383-07"},{"key":"e_1_2_10_74_2","first-page":"S299","article-title":"Ligands for Siglec\u20108 and Siglec\u2010F","volume":"119","author":"Guo J","year":"2007","journal-title":"binding characteristics and tissue distribution"},{"key":"e_1_2_10_75_2","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.200800039"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2222.2008.03173.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2222.2008.03173.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T22:05:41Z","timestamp":1697407541000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2222.2008.03173.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,28]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["10.1111\/j.1365-2222.2008.03173.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2222.2008.03173.x","archive":["Portico"],"relation":{},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,28]]}}}